Syngene International, a subsidiary of Biocon, and Bristol-Myers Squibb Company has opened a new R&D facility for Bristol-Myers Squibb in Biocon Park, Bangalore, India. The 200,000 square-foot facility
The Task Force reviewed new evidence on the benefits and harms of screening children and adolescents for clinical depression, the accuracy of screening tests administered in the primary
According to Diamyd Medical, the Endomorphin technology embodies a direct production and release of endomorfin peptides with morphine-like activity directly into the spinal cord blocking further pain signal
Additionally, the first patient was successfully treated using the Cryo1 system by Niv Ad, the chief of cardiac surgery at Inova Fairfax Hospital Department of Cardiovascular and Thoracic
Dr Chiswell has been involved with Nabriva since its foundation, having served as chairman of the supervisory board for the past three years. He is currently chairman of
Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures. Topiramate tablets are also indicated
Takeda said that it conducted the Phase III trial of Takepron for the treatment of Japanese patients who take low-dose aspirin in long period and submitted an application
Thomas, McNerney & Partners led the round along with a substantial investment from Split Rock Partners and insider investments from Prism Ventures, Tullis-Dickerson and Vector Group. With this
The marketing authorization application (MAA) for Cleviprex was submitted via the decentralized procedure, with the UK acting as the reference member state. Concerned member states participating in the
Co-investing in the Series A funding are Latterell Venture Partners of San Francisco, California, VantagePoint Venture Partners of San Bruno, California and Adams Street Partners of Chicago, Illinois.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.